From: Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research
Interview | Stakeholder group | Country |
---|---|---|
A | Academia | Ireland |
B | University hospital | Belgium |
C | Not-for-profit research organisation | The Netherlands |
D | Consultancy and private bank (2 participants) | Belgium |
E | Not-for-profit organisation | The UK |
F | Not-for-profit organisation | Belgium |
G | Health technology assessment body | Belgium |
H | Not-for-profit research organisation | Belgium |
I | University hospital | Belgium |
J | Governmental funding organisation | The Netherlands |
K | Academia | Belgium |
L | Not-for-profit research organisation | Belgium |
M | Academia | Belgium |
N | Pharmaceutical industry (2 participants) | Belgium |